Your browser is no longer supported. Please, upgrade your browser.
Settings
OVAS OvaScience, Inc. daily Stock Chart
OVAS [NASD]
OvaScience, Inc.
Index- P/E- EPS (ttm)-0.92 Insider Own0.50% Shs Outstand35.78M Perf Week12.90%
Market Cap27.55M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float33.45M Perf Month0.00%
Income-33.00M PEG- EPS next Q- Inst Own38.40% Short Float3.28% Perf Quarter-17.55%
Sales0.30M P/S91.84 EPS this Y44.20% Inst Trans-15.65% Short Ratio5.29 Perf Half Y-10.41%
Book/sh1.40 P/B0.55 EPS next Y- ROA-48.20% Target Price15.00 Perf Year-45.77%
Cash/sh1.50 P/C0.51 EPS next 5Y- ROE-54.00% 52W Range0.66 - 1.65 Perf YTD-45.00%
Dividend- P/FCF- EPS past 5Y9.30% ROI-78.80% 52W High-53.33% Beta3.41
Dividend %- Quick Ratio11.40 Sales past 5Y- Gross Margin-40.00% 52W Low16.47% ATR0.05
Employees36 Current Ratio11.40 Sales Q/Q0.00% Oper. Margin- RSI (14)53.13 Volatility5.57% 6.15%
OptionableYes Debt/Eq0.00 EPS Q/Q57.80% Profit Margin- Rel Volume0.64 Prev Close0.72
ShortableYes LT Debt/Eq0.00 EarningsAug 09 AMC Payout- Avg Volume207.32K Price0.77
Recom2.00 SMA205.54% SMA50-5.44% SMA200-20.13% Volume133,626 Change7.00%
Apr-18-17Resumed Credit Suisse Underperform
Jan-25-16Downgrade Oppenheimer Outperform → Perform
Jan-21-16Initiated Credit Suisse Underperform
Nov-09-15Downgrade Leerink Partners Outperform → Mkt Perform
Oct-21-15Reiterated Oppenheimer Outperform $12 → $16
Sep-30-15Reiterated Oppenheimer Outperform $60 → $12
Sep-29-15Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jun-29-15Initiated JP Morgan Neutral $40
Jan-21-15Reiterated Oppenheimer Outperform $55 → $60
Dec-24-14Upgrade Oppenheimer Perform → Outperform
Dec-18-14Reiterated H.C. Wainwright Buy $40 → $100
Nov-11-14Reiterated H.C. Wainwright Buy $16 → $40
Oct-08-14Downgrade Oppenheimer Outperform → Perform $11
Apr-29-14Initiated Oppenheimer Outperform $11
Aug-12-18 12:41AM  [$$] Drugmaker Millendo Going Public Via Reverse Merger The Wall Street Journal
Aug-10-18 01:53PM  OvaScience's future uncertain after merger with Michigan biotech American City Business Journals +6.65%
Aug-09-18 04:10PM  OvaScience: 2Q Earnings Snapshot Associated Press -14.47%
04:01PM  OvaScience Reports Second Quarter 2018 Financial Results and Provides Strategic Alternatives Update Business Wire
09:57AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of OvaScience, Inc. to Millendo Therapeutics, Inc. is Fair to Shareholders GlobeNewswire
07:00AM  OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company Business Wire
Jul-17-18 07:25AM  Free Technical Research on OPKO Health and Three More Biotech Equities ACCESSWIRE
Jul-12-18 04:50AM  Edited Transcript of OVAS earnings conference call or presentation 9-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-07-18 12:02PM  Flavor Of The Month: OvaScience And More Simply Wall St.
May-03-18 05:07PM  OvaScience: 1Q Earnings Snapshot Associated Press
04:01PM  OvaScience Reports First Quarter 2018 Financial Results and Provides Business Update Business Wire
Mar-16-18 01:05PM  Edited Transcript of OVAS earnings conference call or presentation 15-Mar-18 8:30pm GMT Thomson Reuters StreetEvents
Mar-15-18 06:42PM  OvaScience reports 4Q loss Associated Press -5.34%
04:01PM  OvaScience Reports Fourth Quarter and Year-End 2017 Financial Results Business Wire
12:00PM  OvaScience, Inc. to Host Earnings Call ACCESSWIRE
07:42AM  Does OvaScience Incs (NASDAQ:OVAS) Past Performance Indicate A Stronger Future? Simply Wall St.
Mar-12-18 04:02PM  OvaScience Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Mar-08-18 04:02PM  OvaScience to Host Fourth Quarter and Fiscal Year 2017 Financial Results Conference Call Business Wire
Mar-04-18 11:02AM  Best Growth Stock in March Simply Wall St.
Jan-31-18 04:59PM  Why OvaScience Inc (NASDAQ:OVAS) Is A Financially Healthy Company Simply Wall St.
Jan-22-18 10:30AM  FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against OvaScience, Inc. (OVAS) & Lead Plaintiff Deadline - January 22, 2018 ACCESSWIRE
Jan-18-18 10:31AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against OvaScience, Inc. (OVAS) & Lead Plaintiff Deadline - January 22, 2018 ACCESSWIRE
Jan-17-18 06:18PM  OVASCIENCE INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In OvaScience, Inc. to Contact The Firm Business Wire
03:35PM  OVAS INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of OvaScience, Inc. Investors and Encourages Investors to Contact the Firm Business Wire
Jan-16-18 07:00PM  Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against OvaScience, Inc. (OVAS) and Encourages Investors to Contact the Firm Before January 22, 2018 ACCESSWIRE
Jan-12-18 04:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OvaScience, Inc. - OVAS ACCESSWIRE +6.31%
10:27AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against OvaScience, Inc. (OVAS) & Lead Plaintiff Deadline - January 22, 2018 ACCESSWIRE
Jan-09-18 06:19PM  OVASCIENCE INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In OvaScience, Inc. To Contact The Firm Business Wire
Jan-08-18 05:30PM  Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against OvaScience, Inc. (OVAS) and Encourages Investors to Contact the Firm Business Wire -10.24%
Jan-05-18 03:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OvaScience, Inc. - OVAS ACCESSWIRE -5.22%
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against OvaScience, Inc. (OVAS) & Lead Plaintiff Deadline January 22, 2018 GlobeNewswire
Jan-04-18 07:00AM  OvaScience to Present at the 36th Annual J.P. Morgan Healthcare Conference Business Wire -8.84%
Jan-03-18 04:06PM  OvaScienceSM Announces Corporate Update Business Wire +8.89%
Dec-27-17 07:55PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OvaScience, Inc. - OVAS ACCESSWIRE
Dec-19-17 05:22PM  OVASCIENCE INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In OvaScience, Inc. To Contact The Firm ACCESSWIRE
05:02PM  IMPORTANT OVASCIENCE, INC. INVESTOR REMINDER: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of investors who purchased and suffered losses in OvaScience, Inc. GlobeNewswire
Dec-18-17 03:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OvaScience, Inc. - OVAS ACCESSWIRE
Dec-15-17 11:20AM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Claims Against OvaScience, Inc. Business Wire
Dec-11-17 01:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OvaScience, Inc. - OVAS ACCESSWIRE
Dec-04-17 08:16PM  Robbins Arroyo LLP: OvaScience, Inc. (OVAS) Misled Shareholders According to a Recently Filed Class Action Business Wire
Dec-01-17 06:18PM  OVASCIENCE INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In OvaScience, Inc. To Contact The Firm PR Newswire
Nov-30-17 04:23PM  IMPORTANT OVASCIENCE, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of investors who purchased and suffered losses in OvaScience, Inc. GlobeNewswire
Nov-28-17 05:30PM  Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against OvaScience, Inc. (OVAS) and Encourages Investors to Contact the Firm Business Wire +5.63%
04:57PM  Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against OvaScience, Inc. PR Newswire
Nov-27-17 10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against OvaScience, Inc. (OVAS) & Lead Plaintiff Deadline - January 22, 2018 PR Newswire
Nov-22-17 05:49PM  OVASCIENCE INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In OvaScience, Inc. To Contact The Firm GlobeNewswire
03:38PM  Scott+Scott, Attorneys at Law, LLP Files Federal Class Action Against OvaScience, Inc. Business Wire
Nov-17-17 12:39PM  ETFs with exposure to OvaScience, Inc. : November 17, 2017 Capital Cube
Nov-08-17 07:15AM  Edited Transcript of OVAS earnings conference call or presentation 2-Nov-17 8:30pm GMT Thomson Reuters StreetEvents
Nov-07-17 08:15AM  OvaScience, Inc. :OVAS-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017 Capital Cube
Nov-06-17 12:16PM  ETFs with exposure to OvaScience, Inc. : November 6, 2017 Capital Cube
Nov-02-17 05:27PM  OvaScience reports 3Q loss Associated Press
04:02PM  OvaScience Reports Third Quarter 2017 Financial Results Business Wire
11:30AM  OvaScience, Inc. to Host Earnings Call ACCESSWIRE
Oct-26-17 04:02PM  OvaScience to Host Third Quarter 2017 Financial Results Conference Call Business Wire
Oct-23-17 10:55AM  ETFs with exposure to OvaScience, Inc. : October 23, 2017 Capital Cube -5.23%
Oct-05-17 11:14AM  ETFs with exposure to OvaScience, Inc. : October 5, 2017 Capital Cube
Sep-25-17 10:42AM  ETFs with exposure to OvaScience, Inc. : September 25, 2017 Capital Cube
Sep-12-17 12:30AM  ETFs with exposure to OvaScience, Inc. : September 12, 2017 Capital Cube
Aug-31-17 07:58PM  ETFs with exposure to OvaScience, Inc. : August 31, 2017 Capital Cube
Aug-24-17 10:26AM  OvaScience, Inc. :OVAS-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017 Capital Cube
Aug-13-17 02:16AM  Edited Transcript of OVAS earnings conference call or presentation 3-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-03-17 07:49PM  OvaScience reports 2Q loss Associated Press
04:02PM  OvaScience Reports Second Quarter 2017 Financial Results Business Wire
Jul-27-17 07:00AM  OvaScience to Host Second Quarter 2017 Financial Results Conference Call Business Wire
Jun-22-17 04:11PM  ETFs with exposure to OvaScience, Inc. : June 22, 2017 Capital Cube +30.14%
Jun-21-17 05:18PM  OvaScience Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Business Wire
05:01PM  Walthams OvaScience names new CEO, cuts half its staff American City Business Journals
04:01PM  OvaScience Appoints Christopher Kroeger, M.D., M.B.A., as Chief Executive Officer Business Wire
Jun-13-17 07:00AM  OvaScience Completes Enrollment of 70 Patients in OvaPrime Clinical Study in Women with Primary Ovarian Insufficiency or Poor Ovarian Response Business Wire +5.47%
Jun-05-17 02:38PM  ETFs with exposure to OvaScience, Inc. : June 5, 2017 Capital Cube
Jun-02-17 09:38AM  OvaScience, Inc. :OVAS-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017 Capital Cube
May-23-17 10:32AM  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against OvaScience, Inc. and Encourages Investors with Losses to Contact the Firm PR Newswire
May-22-17 04:55PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in OvaScience, Inc. to Contact the Firm Accesswire
May-10-17 07:16AM  Edited Transcript of OVAS earnings conference call or presentation 9-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-09-17 05:32PM  OvaScience reports 1Q loss Associated Press
04:02PM  OvaScience Reports First Quarter 2017 Financial Results Business Wire
May-05-17 01:22PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against OvaScience, Inc. and Encourages Investors with Losses to Contact the Firm PR Newswire
May-04-17 10:36AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against OvaScience, Inc. (OVAS) and Lead Plaintiff Deadline - May 29, 2017 Accesswire
May-02-17 04:13PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against OvaScience, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
03:14PM  DEADLINE ALERT: Brower Piven Alerts Shareholders of Approaching Deadline in Class Action Lawsuit and Encourages Those with Losses in Excess of $100,000 from Investment in OvaScience, Inc. to Contact the Firm Business Wire
Apr-19-17 05:37PM  SHAREHOLDER ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit Against OvaScience, Inc. Business Wire
04:42PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In OvaScience, Inc. To Contact The Firm PR Newswire
Apr-12-17 02:05PM  Screening for Net-Net Stocks in an Overvalued Market GuruFocus.com
Apr-10-17 07:17PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against OvaScience, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
06:26PM  Robbins Arroyo LLP: OvaScience, Inc. (OVAS) Misled Shareholders According to a Recently Filed Class Action Business Wire
Apr-05-17 10:43AM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against OvaScience, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire -7.27%
10:43AM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against OvaScience, Inc. and Encourages Investors with Losses to Contact the Firm
09:30AM  Zacks.com featured highlights: EV Energy Partners, OvaScience, Galena Biopharma, Amaya and Cenovus Energy Zacks
09:30AM  Zacks.com featured highlights: EV Energy Partners, OvaScience, Galena Biopharma, Amaya and Cenovus Energy
Apr-04-17 10:45PM  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In OvaScience, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit Business Wire -5.17%
10:45PM  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In OvaScience, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
Mar-31-17 11:06AM  INVESTOR ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against OvaScience, Inc. Business Wire
10:55AM  Edited Transcript of OVAS earnings conference call or presentation 2-Mar-17 9:30pm GMT Thomson Reuters StreetEvents
10:55AM  Edited Transcript of OVAS earnings conference call or presentation 2-Mar-17 9:30pm GMT
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against OvaScience, Inc. (OVAS) & Lead Plaintiff Deadline - May 29, 2017 PR Newswire
Mar-30-17 08:01PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against OvaScience, Inc. and Encourages Investors With Losses to Contact the Firm Business Wire
06:30PM  IMPORTANT OVASCIENCE, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of purchasers of OvaScience, Inc. GlobeNewswire
06:30PM  IMPORTANT OVASCIENCE, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of purchasers of OvaScience, Inc.
Mar-29-17 04:52PM  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In OvaScience, Inc. (OVAS) To Contact Brower Piven Before The Lead Plaintiff Deadline GlobeNewswire
OvaScience, Inc., a fertility company, discovers, develops, and commercializes fertility treatment options for women and families struggling with infertility worldwide. Its patented technology is based on the discovery about the existence of egg precursor (EggPC) cells to transform the treatment landscape for women's fertility. The company offers various fertility treatment options, including OvaPrime treatment to restore a woman's egg production by isolating a woman's own EggPC cells within her ovary to mature in vivo into healthy and fertilizable eggs; OvaTure treatment to mature EggPC cells into fertilizable eggs in vitro or outside the body by eliminating the need for hormone stimulation; and AUGMENT treatment to enhance the fertilization and pregnancy rates by using mitochondria from a woman's own EggPC cells. It also provides OvaXon for the prevention of inherited diseases for human and animal health. The company was formerly known as Ovastem, Inc. and changed its name to OvaScience, Inc. in May 2011. OvaScience, Inc. was founded in 2011 and is headquartered in Waltham, Massachusetts.